Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.48 USD | +0.68% | +5.77% | +6.98% |
Mar. 20 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Mar. 20 | Sector Update: Health Care Stocks Down Wednesday Afternoon | MT |
Financials (USD)
Sales 2024 * | 1.21B | Sales 2025 * | 1.27B | Capitalization | 2.97B |
---|---|---|---|---|---|
Net income 2024 * | 57M | Net income 2025 * | 197M | EV / Sales 2024 * | 2.37 x |
Net cash position 2024 * | 102M | Net cash position 2025 * | 231M | EV / Sales 2025 * | 2.16 x |
P/E ratio 2024 * |
45.6
x | P/E ratio 2025 * |
33
x | Employees | 2,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.44% |
Latest transcript on LivaNova PLC
1 day | -1.50% | ||
1 week | +4.44% | ||
Current month | -1.50% | ||
1 month | +1.25% | ||
3 months | +10.33% | ||
6 months | +15.63% | ||
Current year | +6.49% |
Managers | Title | Age | Since |
---|---|---|---|
Alex Shvartsburg
DFI | Director of Finance/CFO | 54 | 16-12-31 |
William Kozy
CHM | Chairman | 72 | 18-06-11 |
Matt J. Dodds
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 20-12-02 | |
Peter Wilver
BRD | Director/Board Member | 64 | 22-06-12 |
William Kozy
CHM | Chairman | 72 | 18-06-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 55.35 | +0.45% | 200 543 |
24-04-25 | 55.1 | -1.50% | 536,705 |
24-04-24 | 55.94 | +1.67% | 977,319 |
24-04-23 | 55.02 | +1.87% | 661,198 |
24-04-22 | 54.01 | +3.21% | 733,740 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.49% | 2.97B | |
-2.92% | 185B | |
-3.80% | 105B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+4.06% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- LIVN Stock